"Benzoxazoles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D001583
|
| MeSH Number(s) |
D03.633.100.221
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Benzoxazoles".
Below are MeSH descriptors whose meaning is more specific than "Benzoxazoles".
This graph shows the total number of publications written about "Benzoxazoles" by people in this website by year, and whether "Benzoxazoles" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 5 | 2 | 7 |
| 2019 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Benzoxazoles" by people in Profiles.
-
Visualizing the invisible: class excursions to ignite children's enthusiasm for microbes. Microb Biotechnol. 2020 07; 13(4):844-887.
-
Treatment of cardiac transthyretin amyloidosis: an update. Eur Heart J. 2019 12 01; 40(45):3699-3706.
-
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice. JACC Heart Fail. 2019 08; 7(8):709-716.
-
Tafamidis for Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2019 01 10; 380(2):196-197.
-
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018 Sep 13; 379(11):1007-1016.
-
Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure-Activity As Potential Antituberculosis Agents. J Med Chem. 2018 06 14; 61(11):4739-4756.
-
Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular Amyloidosis. J Stroke Cerebrovasc Dis. 2018 Sep; 27(9):e212-e214.
-
PPAR Agonists and Metabolic Syndrome: An Established Role? Int J Mol Sci. 2018 Apr 14; 19(4).
-
Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension. J Med Chem. 2018 04 12; 61(7):2725-2736.
-
A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer. Invest New Drugs. 2018 06; 36(3):458-467.